Formulation Development continues to expand capabilities - September 18, 2017
The QCL Formulation Development group continues to expand as GMP manufacturing for clinical materials comes into view for Q1 2018.
Successful FDA Inspection - July 26, 2017
QCL is pleased to announce the successful completion of an unannounced general GMP inspection from July 24 through July 27 by two FDA Consumer Safety Officers. QCL is committed to high levels of scien
QCL adds capacity and capabilities - May 20, 2017
QCL's new 35,000 square foot facility adds analytical capacity for Finished Products and API's and brings the total to about 90,000 square feet. The new facility also expands the formulation developme